Active ingredientCefmenoximeCat. No. P-C085-001CAS 65085-01-0Family · Pharmaceutical analytical standards
Cefmenoxime
An injectable third-generation cephalosporin, described in Japan in the late 1970s and patented in 1978, given intramuscularly or intravenously against bacterial infections. This family brings together the active ingredient and other impurities.
Did you know?It did not remain just an injection: as early as 1984 Japanese ophthalmologists published the first clinical studies of cefmenoxime eye drops for external eye infections.
Go to the active ingredient →Active ingredientCefmenoximeCat. No. P-C085-001CAS 65085-01-0
Active ingredientCefmenoxime HClCat. No. P-C085-002CAS 75738-58-8
ImpurityCefmenoxime Impurity 1Cat. No. P-C085-003CAS 126747-52-2
ImpurityCefmenoxime Impurity 2Cat. No. P-C085-004CAS 68350-02-7
ImpurityCefmenoxime Impurity 3Cat. No. P-C085-005
ImpurityCefmenoxime Impurity 4Cat. No. P-C085-006
ImpurityCefmenoxime Impurity 5Cat. No. P-C085-007
ImpurityCefmenoxime Impurity 6Cat. No. P-C085-008
ImpurityCefmenoxime Impurity 7Cat. No. P-C085-009
ImpurityCefmenoxime Impurity 8Cat. No. P-C085-010
ImpurityCefmenoxime Impurity 9Cat. No. P-C085-011CAS 1597415-32-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.